- Home
- TARS vs TRS Comparison
TARS vs TRS Comparison
Compare TARS & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- TRS
- Stock Information
- Founded
- TARS 2016
- TRS 1986
- Country
- TARS United States
- TRS United States
- Employees
- TARS N/A
- TRS N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- TRS Industrial Specialties
- Sector
- TARS Health Care
- TRS Industrials
- Exchange
- TARS Nasdaq
- TRS Nasdaq
- Market Cap
- TARS 1.7B
- TRS 1.5B
- IPO Year
- TARS 2020
- TRS 2007
- Fundamental
- Price
- TARS $51.69
- TRS $39.12
- Analyst Decision
- TARS Strong Buy
- TRS Strong Buy
- Analyst Count
- TARS 7
- TRS 2
- Target Price
- TARS $67.14
- TRS $45.00
- AVG Volume (30 Days)
- TARS 679.4K
- TRS 592.2K
- Earning Date
- TARS 11-12-2025
- TRS 11-03-2025
- Dividend Yield
- TARS N/A
- TRS 0.41%
- EPS Growth
- TARS N/A
- TRS N/A
- EPS
- TARS N/A
- TRS 0.91
- Revenue
- TARS $295,521,000.00
- TRS $973,840,000.00
- Revenue This Year
- TARS $33,170.29
- TRS $11.03
- Revenue Next Year
- TARS N/A
- TRS $6.13
- P/E Ratio
- TARS N/A
- TRS $43.32
- Revenue Growth
- TARS 254.45
- TRS 6.72
- 52 Week Low
- TARS $30.23
- TRS $19.33
- 52 Week High
- TARS $59.76
- TRS $39.71
- Technical
- Relative Strength Index (RSI)
- TARS 46.25
- TRS 62.43
- Support Level
- TARS $48.20
- TRS $37.85
- Resistance Level
- TARS $59.76
- TRS $39.69
- Average True Range (ATR)
- TARS 2.04
- TRS 0.93
- MACD
- TARS -1.29
- TRS -0.17
- Stochastic Oscillator
- TARS 30.19
- TRS 71.63
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.